E
Erika D. Feller
Researcher at University of Maryland Medical Center
Publications - 54
Citations - 1706
Erika D. Feller is an academic researcher from University of Maryland Medical Center. The author has contributed to research in topics: Ventricular assist device & Medicine. The author has an hindex of 13, co-authored 42 publications receiving 1489 citations. Previous affiliations of Erika D. Feller include University of Maryland, Baltimore & Temple University.
Papers
More filters
Journal ArticleDOI
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
Maria Rosa Costanzo,Maya Guglin,Mitchell T. Saltzberg,Mariell Jessup,Bradley A. Bart,John R. Teerlink,Brian E. Jaski,James C. Fang,Erika D. Feller,Garrie J. Haas,Allen S. Anderson,Michael P. Schollmeyer,Paul A. Sobotka +12 more
TL;DR: In decompensated HF, ultrafiltration safely produces greater weight and fluid loss than intravenous diuretics, reduces 90-day resource utilization for HF, and is an effective alternative therapy.
Journal ArticleDOI
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Hobart Rogers,Joanne Marshall,Jeremy S. Bock,Thomas C. Dowling,Erika D. Feller,Shawn W. Robinson,Stephen S. Gottlieb,Stephen S. Gottlieb +7 more
TL;DR: During a 48-hour period, UF did not cause any significant differences in renal hemodynamics compared with the standard treatment of intravenous diuretics.
Journal ArticleDOI
Clinical Outcomes Are Similar in Pulsatile and Nonpulsatile Left Ventricular Assist Device Recipients
Erika D. Feller,Erik N. Sorensen,Michel Haddad,Richard N. Pierson,Frances L. Johnson,James M. Brown,Bartley P. Griffith +6 more
TL;DR: There was no significant difference between groups in pre-LVAD disease severity indicators, and Similarly ill congestive heart failure patients benefited equally well from either a nonpulsatile or a pulsatile LVAD, which may support an expanded role for nonpulse LVADS in the treatment of severe heart failure.
Journal ArticleDOI
Allograft Inflammatory Factor-1 Expression Correlates With Cardiac Rejection and Development of Cardiac Allograft Vasculopathy
Michael V. Autieri,Sheri E. Kelemen,Bernadette A. Thomas,Erika D. Feller,Bruce I. Goldman,Howard J. Eisen +5 more
TL;DR: Expression of Aif-1 in cardiac allografts correlates with rejection, and the amount of AIF-1 expressed correlates with the severity of rejection.
Journal ArticleDOI
Cell-Free DNA to Detect Heart Allograft Acute Rejection
Sean Agbor-Enoh,Palak Shah,Ilker Tunc,Steven Hsu,Stuart D. Russell,Erika D. Feller,Keyur B. Shah,Maria E. Rodrigo,Samer S. Najjar,H. Kong,Mehdi Pirooznia,U. Fideli,Alfiya Bikineyeva,A. Marishta,K. Bhatti,Yanqin Yang,C. Mutebi,C. Mutebi,Kai Yu,Moon Kyoo Jang,Charles C. Marboe,Gerald J. Berry,Hannah A. Valantine +22 more
TL;DR: In this paper, after heart transplantation, endomyocardial biopsy (EMBx) is used to monitor for acute rejection (AR), but EMBx is invasive and its conventional histological interpretation is wrong.